‘Major’ Dejan Kulusevski injury update given ahead of Europa League final vs Man Utd – reporter

3 Min Read

Tottenham Hotspur’s biggest game in many years awaits next week as they prepare to take on Manchester United in the Europa League final.

Tottenham have endured a dismal season at domestic level, but they’re now just one game away from winning their first trophy since 2008.

Ange Postecoglou has had a number of personnel issues to contend with ahead of the game, including Dejan Kulusevski’s fitness.

The Sweden international hobbled off during the weekend loss to Crystal Palace.

However, Paul O’Keefe has now shared an update on Kulusevski that suggests Tottenham may well be trying all they can to get him on the Bilbao pitch.

Tottenham star Dejan Kulusevski ‘having pain-killing injections in his knee’

A Tottenham fan asked O’Keefe about Kulusevski’s fitness on X, and the Spurs expert shared an update from behind the scenes.

O’Keefe explained how Kulusevski is now having pain-killing injections in his knee and, while he’s a “major doubt” for the game, he’s not ruled out completely just yet.

A rumour has also been doing the rounds suggesting Lucas Bergvall could have a chance of making the final.

What Ange Postecoglou recently said about Dejan Kulusevski fitness

Speaking to reporters on Monday, Postecoglou said the initial assessment was that Kulusevski had suffered a knock.

“He was a bit sore this morning with his knee,” Postecoglou told reporters. “It looks like a knock at this stage.

“We are going to let it settle for 24 hours and then assess it but the initial thing is it is more of a knock than anything more significant. Fingers crossed he is OK.”

However, O’Keefe’s update suggests that Kulusevski’s issue is more serious than first thought, though Spurs don’t seem to have given up on him playing in the final.

James Maddison and Radu Dragusin are set to be out for the rest of the season due to respective knee injuries, while Bergvall is also likely to be out.

This post was originally published on this site

Share This Article
Exit mobile version